stir for 20 min. Potassium carbonate (5.15 g, 37.31 mmol) was
added, and the mixture was allowed to stir at room temperature
for 12 h. The solution was then distilled under reduced pressure
to remove N,N-dimethylformamide. To the residue was added
dichloromethane and water. The water phase was extracted with
dichloromethane. The combined organic phase was dried over
sodium sulfate, filtered and rotary evaporated. The crude product
was dissolved in methanol (200 mL) and acetic acid glacial
(120 mL) and stirred for 8 h at 45–50 ◦C. The solution was
rotary evaporated, and the crude product was purified by column
chromatography (petroleum ether/EtOAc, 2 : 1 then 1 : 1◦, v/v) to
give 7.49 g (60%) of 8a as a white solid. mp 182–183 C; [a]D20
rotary evaporated, and the crude product was purified by column
chromatography (CH2Cl2–EtOAc, 3 : 1, v/v◦) to give 0.62 g (55%)
of 10a as a light-yellow solid. mp 260–261 C; [a]2D0 -94.4 (c 0.5,
DMF); 1H NMR (400 MHz, DMSO-d6): d 10.41(s, 1 H, Ar–OH),
8.99 (s, 1 H, Ar–H), 8.14 (d, J = 8.8 Hz, 1 H, Ar–H), 8.02 (d, J =
2.0 Hz, 1 H, Ar–H), 7.95 (s, 1 H, Ar–H), 7.23 (dd, J = 2.0, 8.8 Hz,
1 H, Ar–H), 5.55 (d, J = 18.4 Hz, 1 H, 9-H), 4.78 (d, J = 18.0 Hz,
1 H, 9-H), 4.54–4.57 (m, 1 H,13a-H), 4.02 (s, 3 H, OMe), 3.91 (s, 3
H, OMe), 2.30–2.44 (m, 4 H, 12-H, 13-H); 13C NMR (100 MHz,
DMSO-d6) d 196.1, 172.8, 159.2, 149.6, 148.4, 139.6, 133.9, 127.3,
123.7, 123.3, 120.3, 119.8, 117.5, 107.4, 106.7, 103.5, 60.5, 55.3,
55.1, 39.9, 29.4, 20.4. HRMS (ESI): calcd. for C22H19NO5 [M +
Na]+ 400.1155; found 400.1152
1
-56.0 (c 1.0, CH2Cl2); H NMR (400 MHz, CDCl3): d 8.03 (d,
J = 8.8 Hz, 1 H, Ar–H), 7.97 (d, J = 2.4 Hz, 1 H, Ar–H), 7.78 (s,
1 H, Ar–H), 7.52–7.54 (m, 2 H, Ar–H), 7.40–7.44 (m, 2 H,Ar–H),
7.34–7.37 (m, 2 H, Ar–H), 7.31 (dd, J = 2.4, 8.8 Hz, 1H, Ar–H),
7.16 (s, 1 H, Ar–H), 5.50 (d, J = 14.4 Hz, 1 H, N–CH2), 5.28 (s,
2 H, benzyl-CH2), 4.40 (d, J = 14.4 Hz, 1 H, N–CH2), 4.09 (s,
3 H, OMe), 4.03 (s, 3 H, OMe), 3.84 (dd, J = 2.8, 9.2 Hz, 1 H,
N–CH), 3.58 (s, 3 H, OMe), 2.55–2.64 (m, 1 H, N–CH–CH2),
2.04–2.48 (m, 1 H, NCO–CH2), 2.08–2.18 (m, 1 H, N–CH–CH2),
1.95–2.02 (m, 1 H, NCO–CH2) 13C NMR (100 MHz, CDCl3) d
174.6, 172.3, 157.4, 149.6, 149.4, 137.0, 131.7, 128.7, 128.1, 127.7,
127.6, 126.6, 126.2, 126.2, 124.6, 124.4, 115.8, 108.2, 106.4, 103.3,
70.4, 58.6, 56.0, 55.9, 52.2, 44.4, 29.8, 22.8. HRMS (ESI): calcd.
for C30H29NO6 [M + Na]+ 522.1887; found 522.1883
(R)-6-Hydroxy-2,3-dimethoxyphenanthro[9,10-b]-11-quinolizi-
dinone(11a). A mixture of 10a (0.41 g, 1.09 mmol), sodium
borohydride (0.12 g, 3.26 mmol) and ethanol (50 mL) was stirred
for 40 min at room temperature. The mixture was cooled to 0 ◦C,
and then 2 mol L-1 hydrochloric acid (10 mL) was added slowly.
Dichloromethane (100 mL) and water (50 mL) was added to the
solution, then the water phase was extracted with dichloromethane
(30 mL). The combined organic phase was dried over sodium
sulfate, filtered, and rotary evaporated, and the product was
dissolved in dry dichloromethane (50 mL), and then triethylsilane
(0.63 g, 5.44 mmol) and trifluoroacetic acid (1.24 g, 20.88 mmol)
was added. The mixture was stirred for 3.5 h at 33–36 ◦C. The
solution was cooled to room temperature, and dichloromethane
(50 mL) and water (50 mL) was added. The water phase was
extracted with dichloromethane (20 mL ¥ 3). The combined
organic phase was rotary evaporated, and the crude product was
purified by column chromatography (petroleum ether/EtOAc,
1 : 3, v/v and then CH2Cl2–EtOAc, 1 : 8, ◦v/v) to give 0.34 g (85%)
of 11a as a light-yellow solid. mp 221 C dec; [a]2D0 -85.6 (c 1,
DMF); 1H NMR (400 MHz, CDCl3): d 7.76 (s, 1 H, Ar–H), 7.74
(s, 1 H, Ar–H), 7.55 (d, J = 8.8 Hz, 1 H, Ar–H), 7.10 (d, J =
8.4 Hz, 1 H, Ar–H), 7.04 (s, 1 H, Ar–H), 6.94 (s, 1 H, OH), 5.30
(d, J = 17.2 Hz, 1 H, 9-H), 4.47 (d, J = 17.2 Hz, 1 H, 9-H),
4.06 (s, 3 H, OMe), 4.01 (s, 3 H,OMe), 3.93–3.94 (m, 1H, 13a-H),
3.30–3.34 (m, 1H, 14-H), 2.53–2.78 (m, 4H, 14-H, 12-H, 13-H),
2.00–2.09 (m, 1H, 13-H); 13C NMR (100 MHz, DMSO-d6) d 173.1,
155.6, 149.0, 148.2, 130.0, 125.7, 124.0, 123.4, 123.2, 122.8, 121.6,
116.5, 106.5, 104.1, 103.9, 55.4, 55.3, 52.3, 40.1, 32.1, 29.4, 24.4.
HRMS (ESI): calcd. for C22H21NO4 [M + H]+ 364.1543; found
364.1540
(R)-1-((6-Benzyloxy-2,3-dimethoxyphenanthren-9-yl)methyl)-5-
oxo-pyrrolidine-2-carboxylic acid (9a). Compound 8a (2.18 g,
4.37 mmol) was stirred in a solution of dioxane (50 mL), methanol
(40 mL) and 2 mol L-1 aqueous potassium hydroxide (30 mL)
for 2 h. The mixture was rotary evaporated to remove dioxane
and methanol, and the resulting mixture was cooled to 0 ◦C and
acidified with 2 mol L-1 hydrochloric acid until pH = 1–2, then
washed with water and dried to give 2.08 g (98%) of 9a as a
◦
white solid. mp 276–278 C; [a]2D0 -67.6 (c 0.5, DMF); 1H NMR
(400 MHz, DMSO-d6): d 8.21 (d, J = 2.4 Hz, 1 H, Ar–H), 8.02 (s,
1 H, Ar–H), 7.96 (d, J = 9.2 Hz, 1 H, Ar–H), 7.57–7.59 (m, 2 H,
Ar–H), 7.40–7.45 (m, 4 H, Ar–H), 7.33–7.37 (m, 1 H, Ar–H), 7.30
(dd, J = 2.4, 9.2 Hz, 1H, Ar–H), 5.38 (d, J = 14.8 Hz, 1 H, N–CH2),
5.37 (s, 2 H, benzyl-CH2), 4.23 (d, J = 15.2 Hz, 1 H, N–CH2), 4.02
(s, 3 H, OMe), 3.91 (s, 3 H,OMe), 3.75 (dd, J = 2.8, 9.2 Hz, 1 H,
N–CH), 2.33–2.43 (m, 2 H, N–CH–CH2, NCO–CH2), 2.13–2.23
(m, 1 H, NCO–CH2), 1.90–1.96 (m, 1 H, N–CH–CH2); 13C NMR
(100 MHz, DMSO-d6) d 174.1, 173.1, 156.9, 149.4, 149.2, 137.1,
131.3, 128.4, 128.0, 127.9, 127.5, 126.3, 125.5, 124.8, 123.9, 123.7,
116.0, 108.5, 106.2, 104.0, 69.5, 58.0, 55.8, 55.4, 43.3, 29.2, 22.4.
HRMS (ESI): calcd. for C29H27NO6 [M - H]+ 484.1766; found
484.1765
(-)-6-O-desmethylantofine (A). A mixture of 11a (0.18 g,
0.50 mmol), lithium aluminium hydride (0.04 g, 1.00 mmol) and
tetrahydrofuran (25 mL) was heated at reflux under nitrogen for
0.5 h. The solution was cooled to 0 ◦C, at which point EtOAc
(10 mL) was added dropwise, followed by water (20 ml). Then
dichloromethane (100 mL) and methanol (50 mL) was added, then
the water phase was extracted with dichloromethane (20 mL ¥ 3).
The combined organic phase was dried over sodium sulfate, filtered
and evaporated, then the product was placed under vacuum in the
dark for ◦2 h to give 0.16◦g (94%) of A as a white solid. mp:
217–218 C (lit.2 226–228 C); [a]2D0 -51.2 (c 0.25, MeOH) (lit.4
[a]2D0 -54.5 (c 0.88, MeOH)); 90% ee [flow rate 1.0 mL min-1,
n-hexane/2-propanol 85 : 15 and 0.1% triethylamine, 254 nm, tR
(major) = 22.75 min, tR (minor) = 25.14 min]. 1H NMR (400 MHz,
(R)-6-Hydroxy-2,3-dimethoxyphenanthro[9,10-b]-11,14-indo-
lizidinedione(10a). To a solution of 9a (1.44 g, 2.97 mmol) in
dry dichloromethane (100 mL) was added oxalyl chloride (0.49 g,
3.86 mmol) and N,N-dimethylformamide (0.1 ml). The mixture
was stirred for 4.5 h at room temperature. Tin(IV) chloride
(0.69 mL, 5.94 mmol) was added slowly under nitrogen at 0 ◦C, and
◦
then the mixture was stirred overnight at 35 C under nitrogen.
The solution was cooled to room temperature, and 2 mol L-1
hydrochloric acid (70 mL) was added. The organic phase was
144 | Org. Biomol. Chem., 2011, 9, 141–145
This journal is
The Royal Society of Chemistry 2011
©